Physician profile
Todd D Clapp
NPI 1013958321
$744.42
in general payments reported to CMS, 2019-2025
16 companies · $63.08 in 2025
The $63.08 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $271 · 2020: $46.67 · 2022: $171 · 2023: $116 · 2024: $76.47 · 2025: $63.08.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $256.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $255.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $234.07 | 2019-2024 | |
| Abbvie INC. | $116.99 | 2023-2024 | Qulipta |
| Glaxosmithkline, LLC. | $82.92 | 2019-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Sanofi-Aventis U.S. LLC | $44.10 | 2019 | |
| Dexcom, INC. | $35.80 | 2022 | |
| Lilly USA, LLC | $29.61 | 2019-2025 | Zepbound, Mounjaro |
| Astrazeneca Pharmaceuticals Lp | $27.79 | 2024-2025 | Breztri, Airsupra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $27.75 | 2019-2022 | |
| Novo Nordisk INC | $27.73 | 2020-2022 | |
| Janssen Pharmaceuticals, INC | $23.55 | 2019 | |
| Amarin Pharma, INC. | $20.83 | 2019 | |
| Hologic Sales and Service, LLC | $18.01 | 2024 | Aptima, Thinprep 2000 Processor |
| Abbott Laboratories | $17.55 | 2020 | |
| Gilead Sciences, INC. | $15.71 | 2025 | |
| Novartis Pharmaceuticals Corporation | $12.19 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dynavax Technologies Corporation | $9.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Clapp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.